Search Results - "Aldouri, M"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation by Aldouri, M A, Wonke, B, Hoffbrand, A V, Flynn, D M, Ward, S E, Agnew, J E, Hilson, A J

    Published in Acta haematologica (1990)
    “…Cardiac scintigraphy has been performed in 60 beta-thalassaemia major patients aged 8-35 years who received regular blood transfusions and subcutaneous…”
    Get more information
    Journal Article
  7. 7

    1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload by Kontoghiorghes, G J, Aldouri, M A, Sheppard, L, Hoffbrand, A V

    Published in The Lancet (British edition) (06-06-1987)
    “…Subcutaneous desferrioxamine, though effective in preventing or reducing iron overload in transfusion-dependent refractory anaemia, is expensive and…”
    Get more information
    Journal Article
  8. 8

    Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine by Aldouri, M A, Wonke, B, Hoffbrand, A V, Flynn, D M, Laulicht, M, Fenton, L A, Scheuer, P J, Kibbler, C C, Allwood, C A, Brown, D

    Published in Journal of clinical pathology (01-11-1987)
    “…Liver biopsies were performed on 51 regularly transfused patients with beta thalassaemia, age range 5-36 (mean 18.6) years, who had received regular…”
    Get full text
    Journal Article
  9. 9

    The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients by Aldouri, Maadh

    “…Recombinant factor VIIa (rFVIIa, NovoSeven) is effective and appears safe in the management of bleeding episodes and provision of surgical cover in haemophilia…”
    Get more information
    Journal Article
  10. 10

    Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease by Mok, Q, Underhill, G, Wonke, B, Aldouri, M, Kelsey, M, Jefferies, D

    Published in Archives of disease in childhood (01-04-1989)
    “…Thirty two patients with beta thalassaemia and sickle cell disease who were having regular blood transfusions were selected to test the efficacy and…”
    Get full text
    Journal Article
  11. 11

    Reversal of desferrioxamine induced auditory neurotoxicity during treatment with Ca-DTPA by Wonke, B, Hoffbrand, A V, Aldouri, M, Wickens, D, Flynn, D, Stearns, M, Warner, P

    Published in Archives of disease in childhood (01-01-1989)
    “…Auditory neurotoxicity occurred in 13 (26%) of 50 evaluable patients receiving long term desferrioxamine chelation. In five of these patients, all of whom were…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Deletion of chromosome arm 15q and hitherto unreported duplication of del(15q) in myeloid disorders by Saunders, K., Williams, Y., Aldouri, M., Telford, N., Czepulkowski, B.

    Published in Cancer genetics and cytogenetics (01-06-2004)
    “…Deletion of the long arm of chromosome 15 has been described as a recurrent chromosomal abnormality in myeloid malignancies. We present here some additional…”
    Get full text
    Journal Article
  14. 14

    Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes by Saunders, K., Czepulkowski, B., Sivalingam, R., Hayes, J.P.L.A., Aldouri, M., Sekhar, M., Cummins, M., Ho, A., Mufti, G.J.

    Published in Cancer genetics and cytogenetics (15-01-2005)
    “…Interstitial deletion of the long arm of chromosome 20, as the sole abnormality, is commonly observed in myeloid malignancies, including myeloproliferative…”
    Get full text
    Journal Article
  15. 15

    Racial differences in the energy cost of standardised activities by Geissler, C A, Aldouri, M S

    “…The assumption is currently made by international organisations that individuals of the same size living in the same environment and having the same mode of…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    Severe acquired haemophilia A treated with recombinant factor VIIa by Shafi, T., Jeha, M. T., Black, L., Douri, M. Al

    Published in British journal of haematology (01-09-1997)
    “…Acquired haemophilia can be associated with various conditions including pregnancy, autoimmune diseases and lymphoproliferative disorders, though often no…”
    Get full text
    Journal Article
  19. 19

    Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one by Kontoghiorghes, G J, Aldouri, M A, Hoffbrand, A V, Barr, J, Wonke, B, Kourouclaris, T, Sheppard, L

    “…The main iron chelator used for transfusional iron overload is desferrioxamine, which is expensive, has toxic side effects, and has to be given subcutaneously…”
    Get full text
    Journal Article
  20. 20